Agnieszka Walczyk

The <scp><i>BRAF</i>^V</scp>^600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?

Agnieszka Walczyk, Aldona Kowalska, Artur Kowalik et al. · Clinical Endocrinology · 2013 · 57 citations

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer

Danuta Gąsior‐Perczak, Iwona Pałyga, Monika Szymonek et al. · PLoS ONE · 2018 · 43 citations · Full text

Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the <i> BRAF ^V600E </i> Mutation: A Single-Institution Study

Aldona Kowalska, Agnieszka Walczyk, Artur Kowalik et al. · Thyroid · 2016 · 41 citations

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer

Tomasz Trybek, Agnieszka Walczyk, Danuta Gąsior‐Perczak et al. · Endocrinology · 2019 · 40 citations · Full text

Engineering, Tert Promoter Mutations, Genetics +17

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence

Aldona Kowalska, Agnieszka Walczyk, Iwona Pałyga et al. · PLoS ONE · 2016 · 29 citations · Full text